A Status Report, Accessibilty and Affordability of Prescription Drugs for Older Americans: (includes a Directory of Pharmaceutical Manufacturer Indigent Patient Programs) : a Staff Report of the Special Committee on Aging, United States Senate, Volume 4
U.S. Government Printing Office, 1992 - Aged - 94 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Section 2GovernmentFunded Prescription Drug Programs for Older Ameri
Directory of Pharmaceutical Manufacturer Indigent Patient Programs
4 other sections not shown
Adria Allergan Amgen Bristol-Myers BRISTOL-MYERS SQUIBB Burroughs-Wellcome Cardizem Ciba-Geigy company indicated company reported company requires company's completed copayments or cost-sharing Cytovene Director drug benefit drug insurance drug manufacturers drug price increases elderly Eminase enrolled Epogen forms are obtained free of charge Genentech grams gross family income hospital indigent patient program insurance coverage Medicaid Medicaid program Medicare medications Medigap Merck Merrell DOW MFGR months Neupogen Norplant NUMBER OF PATIENTS outpatient prescription drug paid out-of-pocket Parke-Davis patient eligibility criteria PATIENTS SERVED percent Pfizer pharmaceutical pharmaceutical manufacturers pharmaceutical products pharmacist pharmacy physician prescription drug prescription drug costs prescription drug coverage private insurance products are covered products are obtained products are sent PROGRAM CHARACTERISTICS PROGRAM The company quantity refills reimbursement request Restrictions rolled sales representative Sargramostim Schering-Plough scription drug Searle sent for distribution SmithKline specific forms supply Syntex third-party tients Upjohn Wyeth-Ayerst